Kenneth Hoberman

Kenneth Hoberman

DirectoratNuvectis Pharma· In proxies 2023–2025

Kenneth Hoberman sits on 2 public boards.

Boards1

  • Nuvectis PharmaDirector · 4 yr on the boardIndependentAudit, Compensation (Chair)—Paid as an executive

Board seats come from each company's latest proxy statement.

Experience

  1. Nuvectis PharmaPublic company · 2 yr
    • Director2024 – Present · 2 yrStock in role +121%
  2. TG TherapeuticsPublic company · 3 yr
    • Director2023 – Present · 3 yrNo stock prices for these years

Roles come from the proxy statements of each company.

Activity

No new filings about this person in the feed.

For the press:Download CSVDownload PNGHow to use our data

Two people shown as one, or a wrong number?